Back
Koninklijke DSM N.V.
Below you will find information from the register publication of inside information. The information has been provided by the organisation.
- Registration date 21 dec 2010 - 07:44
- Statutory name Koninklijke DSM N.V.
- Title DSM to acquire Martek to add new Nutrition growth platform
- Comments DSM (NYSE Euronext: DSM KON) to offer US$31.50 for each share of Martek Biosciences Corporation (NASDAQ: MATK) in an all-cash transaction (through a tender offer) Total consideration of US$1,087 million (about EUR829 million) Offer price represents 35% premium to Martek`s closing share price on December 20, 2010 Martek Board of Directors recommends the offer Acquisition adds new growth platform for natural, healthy Polyunsaturated Fatty Acids (PUFAs) nutrition ingredients (Omega-3 DHA and Omega-6 ARA) PUFAs are clinically proven to have important human health benefits. Martek is a leader in this field with strong positions, especially in Infant Formula Nutrition applications
Related downloads
| 201012210000000005_DSM_eng_PR.pdf |
| 201012210000000005_DSM_eng_Presentation.pdf |
Date last update: 10 August 2022
Share information